Evaluating Bone Microarchitecture and Strength in Women With HIV
Bone microarchitecture and strength are reduced in women living with HIV, and tenofovir treatment may contribute to bone deficits.
Osteoporosis
Inhibition of Sclerostin May Increase Cardiovascular Risk
Inhibition of sclerostin with romosozumab may increase cardiovascular risk.
Safety and Efficacy of Romosozumab Demonstrated in Postmenopausal Women With Mild to Moderate CKD
The safety and efficacy of romosozumab for osteoporosis treatment in postmenopausal women are not significantly affected by reduced kidney function.
Hand Osteoarthritis Associated With Changes in Bone Architecture and Strength
Researchers assessed the impact of primary hand osteoarthritis on bone mass, microstructure, and biomechanics in the affected skeletal regions.
Low Physical Function, Lean Body Mass Predict Accelerated Bone Loss After Hip Fracture
Lower physical function and lean body mass are associated with increased risk for accelerated bone loss in older patients with previous hip fracture.
Abaloparatide Effective for Younger Postmenopausal Women at High Fracture Risk
Abaloparatide treatment significantly increases bone mineral density in younger postmenopausal women at high risk for fracture.
Osteoporotic Fracture Risk Lower With DOACs Than Warfarin in Atrial Fibrillation
For patients with atrial fibrillation, the risk for osteoporotic fracture appears to be lower with direct oral anticoagulant use compared with warfarin use.
High-Density Lipoprotein May Be a Predictor of Osteoporosis in Rheumatoid Arthritis
Researchers explored the clinical significance of high density lipoprotein in patients with and without osteoporosis with rheumatoid arthritis.
Updated AACE/ACE Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis: What Do Clinicians Need to Know?
The ACE and AACE released a 2020 update to their clinical practice guidelines for the treatment and diagnosis of postmenopausal osteoporosis.
Dairy Intake Not Found to Affect BMD During Menopausal Transition
Level of dairy intake does not affect the rate of bone mineral density loss or fracture risk among perimenopausal women.
-
Loading...
-
Loading...
Next post in Bone Metabolism
